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 Medical imaging has evolved in leaps and bounds during the last century. Several 
medical imaging modalities such as X-rays, single photon emission computer tomography 
(SPECT), positron emission tomography (PET), computer tomography (CT), magnetic 
resonance imaging (MRI) have been developed. However, MRI has a distinct advantage 
over most of these imaging techniques. MRI does not use ionizing radiation, and hence, is 
considered a safer option for noninvasive imaging.  However, every imaging modality 
comes with its set of limitations and challenges. Although quantitative myocardial 
perfusion MRI has been studied by researchers over a few decades, it has still not developed 
into a clinical tool. There is no consensus on the choice of imaging protocol to be used. 
The scientific community is still divided on the choice of pharmacokinetic model to be 
used for quantification of myocardial perfusion. In this dissertation, novel techniques were 
developed and implemented to address a few of the challenges faced by fully quantitative 
myocardial perfusion MRI. We strive to make it simpler and more accurate. It is with the 
development of such easy-to-use techniques that cardiac perfusion MRI will find 
increasing clinical use. These developments are a step in the transition of quantitative 
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Medical imaging has evolved with leaps and bounds in the last century. Several 
medical imaging modalities such as X-rays, single photon emission computer tomography 
(SPECT), positron emission tomography (PET), computer tomography (CT), and magnetic 
resonance imaging (MRI) have developed. However, MRI has a distinct advantage over 
most of these imaging techniques. MRI does not use ionizing radiation, and hence, is a 
safer choice for noninvasive imaging. The absence of ionizing radiation makes MRI a 
viable choice for longitudinal studies [2].  Thus, several novel MR imaging methods such 
as dynamic contrast enhanced imaging, T1/T2 mapping, late gadolinium imaging, and 
phase contrast imaging have been developed.  
1.1.1 MR image formation 
MRI derives its signal from the spinning protons in the human body. These spinning 
protons, acting as magnetic dipoles, are randomly oriented in the body. However, under 
the influence of a strong magnetic field of the MR magnet, the protons get aligned in the 
direction of the magnetic field. If energy in the form of a radiofrequency (RF) pulse is 




magnetic field. Once tipped, the spinning protons can induce current in an external 
conductor per Faraday’s law. This induced current is the MR signal that is used to generate 
images.  
The MRI scanner acquires the data in the frequency domain, also known as k-space. 
The scanner fills the k-space in a predefined manner. Under an ideal case, the scanner 
acquires the k-space completely by reading samples at a rate greater than the Nyquist rate. 
An inverse Fourier transform is then performed to obtain the images from the acquired k-
space. Figure 1.1 (a) and (b) represent the relationship between the image and its k-space. 
However, for some applications, the image must be rapidly acquired to freeze motion. 
Under such circumstances, it is not possible to acquire the complete k-space in such a short 
duration. Hence, a highly undersampled acquisition is used. The scanner only acquires 
some part of the k-space. Figure 1.1 (d) shows an under-sampled k-space where the scanner 
has only acquired 24 radial lines in the k-space. If inverse Fourier transform is applied to 
such an undersampled k-space, it leads to aliasing/streaking in the images. Hence, 
compressed-sensing-based iterative reconstruction techniques must be used to obtain 
usable images. 
 
1.1.2 MR image contrast 
As described earlier, the application of a RF pulse causes the protons to tip away 
from the direction of the strong external magnetic field. Once tipped, the protons slowly 
start returning to their equilibrium state, i.e., aligning back in the direction of the external 
magnetic field. The dynamics of the protons trying to return to their equilibrium positions 




be used to define two relaxation rates, namely, the T1 relaxation rate and the T2 relaxation 
rate. The T1 relaxation rate or the spin-lattice relaxation rate controls the rate at which the 
protons return to their equilibrium state. The T2 relaxation rate or the spin-spin relaxation 
rate gives a measure of the tendency of the spins to dephase, thereby leading to a loss in 
the MR signal. The various MR imaging techniques exploit the differences between these 
tissue relaxation rates to achieve contrast in the MR images. Dynamic contrast-enhanced 
MRI (DCE-MRI) goes a step further by using external agents to alter these relaxation rates 
of the tissue under consideration. These changes in the relaxation rates over time can be 
tracked using MRI to gain valuable information [3]. 
 
1.1.3 T1-weighted DCE-MRI 
T1-weighted DCE-MRI is a technique in which a paramagnetic contrast agent, 
usually a gadolinium based contrast agent, is injected intravenously. The T1 relaxation rate 
of the tissue reduces depending on the contrast agent concentration at the location. T1-
weighted images of the organ under study are rapidly acquired to track the changes in the 
T1 relaxation rate over time. These changes in the T1 relaxation rate represent the contrast 
agent dynamics. For diagnosis, the clinicians visually analyze these contrast agent 
dynamics. Most commonly, DCE-MRI is used to study the tumor hemodynamics. DCE-
MRI is also used to look at perfusion in various organs of the body such as the brain, liver, 
kidney, prostate, etc. One such interesting application of DCE-MRI is to look at the 
perfusion in the myocardium noninvasively. In this dissertation, we study few of the 
challenges faced by the T1-weighted DCE-MRI of the myocardium, also known as 




1.2 Myocardial perfusion MRI 
Cardiovascular diseases are responsible for almost 17 million deaths per year 
worldwide. DCE-MRI of the heart is a useful tool for detection of certain types of 
cardiovascular diseases [4]. A gadolinium-based contrast agent is injected rapidly as a 
bolus. This contrast agent goes into the heart and then into the myocardium via the coronary 
arteries. During the passage of this contrast agent, imaging slices are rapidly acquired 
through the heart. This is done to track the uptake and washout of the contrast agent over 
time [5]. Figure 1.2 (a-j) shows a single slice from one of the subjects over time. The 
perfusion data is acquired for ~1min to ensure that the first pass of the contrast agent 
dynamics is completely captured. Prior to the arrival of the contrast, the entire myocardium 
along with the blood pool appears uniformly dark. This is known as the precontrast phase. 
Figure 1.2 (a-c) show these precontrast images. After the injection, first the right ventricle 
(RV) appears bright. Figure 1.2 (d) represents this phase. From the RV, the blood along 
with the contrast agent goes into the lungs and back into the heart, i.e., in the left ventricle 
(LV) via the left atrium (LA). This is where the LV appears bright. Figure 1.2 (e-f) 
represent this phase. From the LV, the blood along with the contrast agent gets pumped out 
and goes to various parts of the body. At the same time, it also goes to the myocardium via 
the 3 coronary arteries. If we look at the images, the myocardium appears bright. Figure 
1.2 (g-j). shows this. Under normal conditions, the blood supply to the different parts of 
the myocardium is uniform. Thus, it appears uniformly bright in the images. However, due 
to abnormalities such as ischemia, the blood supply to certain parts of the myocardium is 
reduced. In extreme cases, the blood supply to some parts of the myocardium stops 




conditions such as an ischemia or an infarct, the blood flow along with the contrast agent 
flow to the affected regions is reduced. Since the contrast agent concentration dictates the 
brightness in the image, the region with reduced blood flow appears relatively darker. 
Figure 1.2 (k) shows an image from a different subject with an infarcted myocardium. The 
red arrow points to the region with infarct. This difference in the appearance of the 
normally perfused region and a reduced perfusion region is visually detected by clinicians 
for diagnosis.  
 
1.2.1 Quantification of myocardial perfusion 
Developments in the field of myocardial perfusion MRI have made it possible to 
use pharmacokinetic models to study the contrast agent dynamics. The use of a 
pharmacokinetic model makes it possible to estimate the absolute blood flow (in units of 
ml/min/g) to the different regions of the myocardium. 
 
1.2.1.1 Motivation 
Many times, visual analysis of the perfusion images is not enough to make a correct 
diagnosis. Under certain conditions, visual analysis to make a correct diagnosis may not 
even be possible. For example, in the case of a balanced triple vessel disease (the blood 
supply is uniformly reduced across the myocardium), the myocardium appears to be 
uniform in the perfusion images. Unless the actual blood flow is evaluated, it would be 
impossible for the clinician to catch the underlying condition. Even in the absence of such 
an extreme case, there have been studies that show better diagnostic performance in the 




analysis only [6, 7].  
 
1.2.1.2 Data acquisition 
A breath-held electrocardiogram (ECG)-gated technique is used for the acquisition 
of the perfusion images. This is done so that the different images in the perfusion time-
series are acquired during the same cardiac phase with very little breathing motion. The 
ECG-signal acts as a synchronization signal and prevents blurring due to the presence of 
cardiac motion. Figure 1.3 shows a schematic of an ECG-gated acquisition for a typical 
myocardial perfusion study. As seen from the figure, the scanner starts the acquisition with 
the detection of a R-wave. A set of 3 slices is acquired after a saturation pulse. The scanner 
completes the data acquisition in the R-R interval and then waits for the arrival of a next 
R-wave to repeat the acquisition. The time-series data is usually acquired for 60-70 
heartbeats. 
However, the use of ECG-gating is a problem under certain conditions. The ECG 
signal can get corrupted due to the radiofrequency excitations and the rapidly switching 
gradients [8-11]. Also, the magnetohydrodynamics effect (the generation of electrical 
fields in the conductive blood as it flows through a static magnetic field) can disrupt the 
ECG signal [8]. These problems tend to be more pronounced at higher field strength, such 
as 3T. In addition, many times it is difficult to obtain a good ECG signal because of factors 
such as patient size, shape, and the ECG-lead placement [12]. In absence of a good ECG 
signal, the acquisition of data becomes a problem. Problems with the acquisition, due to 
corrupted ECG signal, can cause errors during the quantification of perfusion. Moreover, 




Breathing motion causes problems when using the data for quantification of perfusion.  To 
address these problems, an ungated or a non-ECG gated acquisition was developed and  
presented in  [13] for visual analysis. Under Chapter 2, we study the use of such a free-
breathing ungated acquisition for the quantification of myocardial perfusion.  
 
1.2.1.3 Tissue curves and arterial input function 
For the quantification of myocardial perfusion, a region of interest (ROI) in 
considered in the myocardium. The average signal in this ROI is recorded over time to 
represent the tissue curve. Similarly, a ROI is drawn in the LV blood pool. The average 
signal from this LV blood pool ROI is recorded over time to get the arterial input function 
(AIF). This is shown by Figure 1.4 (a and b). Considering the myocardial tissue under 
consideration as a single input system, we can say that the AIF is the input to the system 
and the recorded tissue curve is the output. Per the established theories of signal processing, 
the impulse response of the system is given by deconvolving the output of the system with 
the input. Under an ideal noise-free condition, the results of the deconvolution process 
would yield a unique impulse response function. 
A major problem affecting quantitative perfusion, worthy of a mention here, is the 
saturation of the AIF. Ideally the measured signal should increase linearly with increase in 
concentration of the contrast agent. However, it is seen that this linear relation between the 
contrast concentration and the signal does not hold true after a certain concentration limit. 
This concentration limit, above which the signal begins to saturate, depends on the 
acquisition parameters and the pulse sequence used to acquire the data. Not correcting the 




Researchers have proposed various techniques to get a correct AIF. The techniques either 
use a modified acquisition technique, such as a dual bolus or a dual-sequence approach, to 
either acquire an AIF that is not affected by saturation or use the Bloch equations to correct 
the effects of saturation. We discuss more about the saturation of the AIF in Chapter 2 of 
this dissertation. 
 
1.2.1.4 Pharmacokinetic modelling 
As described earlier, we expect the result of the deconvolution between the AIF 
and the tissue curves to give a unique impulse response function. However, under practical 
condition, this is not the case. Hence, the result of the deconvolution operation must be 
constrained to meet certain preset conditions. These conditions or restrictions on the results 
of the deconvolution process are enforced in form of a pharmacokinetic model. This 
process, also known as pharmacokinetic modelling, is the final step in estimating the 
myocardial blood flow. Figure 1.4 (c and d) show this. 
The pharmacokinetic model imposes restrictions on the shape and form of the 
impulse response on the basis of certain assumptions about the physiology of the tissue 
under consideration. Broadly the pharmacokinetic models may be classified as 1) indicator 
dilution theory (IDT) based models, 2) distributed parameter (DP) models, and 3) 
compartment models [14]. The distributed parameter models are the most complex of the 
three categories. However, due to their complexity they suffer from stability issues, and 
hence, are less popular. The indicator dilution theory based models are based on the central 
volume principle. They are more popular compared to the DP models. However, the IDT 




simplest and the model parameters have a physiological interpretation.  
Compartment model-based pharmacokinetic models are commonly used in DCE-
MRI. The underlying assumption for this category of models is that the tissue under 
consideration is be divided into discrete well mixed compartments. Various transfer 
coefficients are defined to represent the flow of contrast agent between compartments. 
Differential equations are written using these transfer coefficients. The solution to the 
differential equations represent the pharmacokinetic model [15]. 
Figure 1.5 shows a high-level schematic of the myocardial tissue sample under 
consideration. The tissue sample may be thought of as two well mixed compartments. The 
cylindrical part corresponds to the intravascular compartment and the remaining part 
outside the vasculature corresponds to the extravascular compartment. The intravascular 
compartment consists of the plasma and the blood cells (represented by black ovals). The 
extravascular compartment includes the myocytes (represented by gray ovals) and the 
extravascular extracellular (EES) space. The third compartment, i.e., intracellular 
extracellular compartment can be lumped with the EES compartment. This is because the 
gadolinium based contrast agent used in myocardial perfusion MRI is an extracellular 
contrast agent. The contrast agent does not permeate across the cell membrane. With the 
fast exchange of water across the cell membrane [1], it can be assumed that the relaxation 
rates are similar inside and outside the cell. This assumption about the fast exchange of 
water may only be true under certain conditions. We talk about this in the discussion under 
Chapter 4. In Figure 1.5, 𝐾𝑡𝑟𝑎𝑛𝑠 and 𝑘𝑒𝑝 stand for the forward and backward rate constant, 
𝑣𝑏 stands for the volume fraction of blood, 𝑣𝑒 stands for the volume fraction of extracellular 




and the tissue, respectively. With these definitions, we can write the differential equation 
for the two-compartment model as: 
𝑑𝐶𝑡𝑖𝑠𝑠(𝑡)
𝑑𝑡
= 𝐾𝑡𝑟𝑎𝑛𝑠𝐶𝑖𝑛(𝑡 − ∆𝑇) − 𝑘𝑒𝑝𝐶𝑡𝑖𝑠𝑠(𝑡).         (1.1) 
Solving the above differential equation, we get, 
𝐶𝑡𝑖𝑠𝑠(𝑡)=𝐶𝑖𝑛(𝑡 − ∆𝑇) ∗ 𝐾
𝑡𝑟𝑎𝑛𝑠𝑒−𝑘𝑒𝑝𝑡.                              (1.2) 
This equation represents the 2-compartment model also known as the Tofts-Kety model 
[16]. In case of the myocardial tissue, the volume fraction of the blood is not negligible. 
Hence, a term corresponding to 𝑣𝑏 must be included in eq. (1.2). The compartment model 
with the 𝑣𝑏 term added is referred to as the extended Tofts-Kety model given by: 
𝐶𝑚𝑦𝑜(𝑡)=𝐶𝑖𝑛(𝑡 − ∆𝑇) ∗ 𝐾
𝑡𝑟𝑎𝑛𝑠𝑒−𝑘𝑒𝑝𝑡 + 𝑣𝑏𝐶𝑖𝑛(𝑡 − ∆𝑇).                    (1.3) 
Here, the term 𝐶𝑚𝑦𝑜 corresponds to the contrast agent concentration in the entire 
myocardium. 𝐶𝑚𝑦𝑜 stands for a combination of the contrast concentration in the tissue and 
in the vasculature. 
 
1.3 Outline of dissertation 
Although quantitative myocardial perfusion has been studied by researchers for 
over a few decades now, it has still not developed into a clinical tool. There is no consensus 
on the choice of the imaging protocol to be used. The scientific community is still divided 
on the choice of the pharmacokinetic model to be used. Moreover, because of the 
complexities of a cardiac MR scan, such as getting a good ECG signal, correct breathing 





today, there are very few studies looking at its repeatability. Thus, quantitative myocardial 
perfusion needs to overcome a few challenges before it develops into a clinical tool. In this 
dissertation, we strive to discuss a few of these challenges. 
The dissertation is divided into 5 chapters, wherein Chapter 1 includes the 
introduction and Chapter 5 is the conclusion. 
In Chapter 2, we look at the problem associated with the poor ECG signal during 
perfusion image acquisition. The standard protocol for the acquisition of myocardial 
perfusion images suggests that an ECG gated acquisition be used. The ECG signal acts as 
a synchronization signal. The R-wave from the ECG acts as a trigger. On detection of the 
R-wave, the scanner starts the acquisition process. However, sometimes the ECG signal 
gets corrupted. Under such circumstances, the scanner either stops the acquisition of data 
completely or misses the valuable information at places. When it comes to perfusion 
imaging, valuable information may be lost if the scanner stops acquisition during the peak 
uptake of the contrast. This can lead to significant errors. Hence, a non-ECG gated 
technique is studied for the quantification of myocardial blood flow (MBF). The accuracy 
of the blood flow estimates using this ungated/self-gated technique is compared to those 
using a standard ECG-gated acquisition. The results show that MBF estimates using a non-
ECG gated acquisition are similar to those using an ECG-gated acquisition during rest.  
In Chapter 3, we look at the repeatability of this ungated/self-gated technique for 
the quantification of perfusion. Although quantitative myocardial perfusion imaging has 
been here for almost two decades now, there have been very few studies looking at its 
precision. This is one of the reasons that it has a label of a “maturing tool” and not a matured 




to adopt the quantitative perfusion imaging for clinical use. In our work, we look at the 
interstudy repeatability of the quantitative perfusion using the previously studied 
ungated/self-gated technique. The results show a good interstudy repeatability for our self-
gated near-systole datasets. The interstudy repeatability is also compared to the previously 
published repeatability studies that make use of an ECG-gated acquisition. We find that 
despite being a non-ECG-gated multislice technique, our repeatability is comparable to or 
better than the previously published studies. 
In Chapter 4, we take a deeper look at the pharmacokinetic modelling technique. 
Division of the tissue under consideration into discrete compartments is the underlying 
principle of compartment model based approach. When using such an approach to quantify 
myocardial perfusion, the extraction fraction has always been a source of debate. Using an 
incorrect value for the extraction fraction can lead to significant underestimation of 
perfusion. Moreover, the use of previously published values of extraction fraction can lead 
to errors since the extraction fraction varies with variation in blood flow. Hence, we study 
the estimation of the extraction fraction as a parameter using pharmacokinetic modeling. 
The proposed technique exploits the information overlap between two different cardiac 
MR imaging techniques, i.e., DCE-MRI and T1 mapping. These two techniques have been 
individually studied to estimate the extracellular volume (ECV). There has been no prior 
study trying to use the overlap between these techniques to improve the perfusion 
estimates. In our study, we use the information about the ECV from T1 mapping to estimate 
the extraction fraction as a parameter during pharmacokinetic modelling. Simulations 
using artificial tissue curves generated with a realistic model are used to test the hypothesis. 




when added information about the ECV is supplied to the pharmacokinetic model. In 
absence of information about the ECV, the pharmacokinetic model does not converge to a 
unique solution. The model is also tested in 6 human datasets at rest and stress. The global 
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Figure 1.1 Figure shows the relationship between the image and its k-space. The scanner 
acquires the data in the k-space. If it samples the k-space at a rate greater than the Nyquist 
rate, the image can be obtained by using inverse Fourier transform. This is shown by (a) 
and (b). However, for cardiac applications, the k-space is highly undersampled to speed 
up the acquisition. Under such a condition, compressed sensing based reconstruction must 






























Figure 1.2 (a-j) Figure shows a single perfusion slice from a subject. We see the uptake 
and washout of the contrast agent in the images. The myocardium is uniformly bright. 
Figure 1.2 (k) shows a single image from a different subject with infarcted myocardium. 
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Figure 1.3 Figure shows a schematic of an ECG-gated acquisition for myocardial 
perfusion. Three imaging slices are acquired. The scanner starts acquiring data with the 
detection of a R-wave. It completely acquires the data in the R-R interval and waits for 
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Figure 1.4 Figure summarizes the process of quantification of myocardial perfusion. A 
region of interest in considered in the LV blood pool and myocardium as shown in (a). 
The signal in this ROI over time gives the AIF and tissue curve as shown in (b). The AIF 
and the tissue curve are fit to a pharmacokinetic model to estimate myocardial perfusion 












































Figure 1.5 Figure shows a high-level schematic of myocardial tissue sample under 
consideration. It can be divided into two discrete compartments, i.e., vascular 
compartment and the extravascular compartment. Ktrans and kep stand for the rate constants 







QUANTIFICATION OF MYOCARDIAL PERFUSION WITH SELF-GATED 
CARDIOVASCULAR MAGNETIC RESONANCE 
 
This chapter is reprinted from “Quantification of myocardial perfusion with self-
gated cardiovascular magnetic resonance” by D. Likhite, G. Adluru, N. Hu, C. McGann 
and E.V.R. DiBella and published in Journal of Cardiovascular Magnetic Resonance, 2015 
17:14. The open access articles published in BioMed Central's journals are made available 



































INTERSTUDY REPEATABILITY OF SELF-GATED QUANTITATIVE 
MYOCARDIAL PERFUSION MRI 
 
This chapter is reprinted from “Interstudy repeatability of self-gated quantitative 
myocardial perfusion MRI” by D. Likhite, P. Suksaranjit ,G. Adluru, N. Hu, C. Weng, E. 
Kholmovski, C. McGann, B. Wilson, E.V.R. DiBella and published in Journal of Magnetic 
























ESTIMATING EXTRACTION FRACTION AND BLOOD FLOW BY COMBINING 
FIRST-PASS MYOCARDIAL PERFUSION 
AND T1 MAPPING RESULTS
 
4.1 Background 
Dynamic contrast enhanced cardiovascular magnetic resonance (DCE-CMR) is a 
commonly used tool for examining myocardial blood flow (MBF) in patients with coronary 
artery disease. Many clinicians favor DCE-CMR because it provides high-spatial and 
temporal resolution and does not require ionizing radiation. In DCE-CMR perfusion, a 
paramagnetic contrast agent is injected as a bolus. The passage of this contrast agent is 
tracked from the blood to the myocardium using T1-weighted imaging. Pharmacokinetic 
modelling techniques are then used to quantify the MBF [1]. Quantifying MBF through 
DCE-CMR studies has been validated by comparison against gold standards such as 
microspheres and positron emission tomography (PET) [2-6]. This technique of 
myocardial blood flow quantification has been shown to complement visual assessment of 
perfusion images [2, 7, 8], as well as being valuable for the study of other cardiac diseases. 
However, while several quantification methods have been developed, fully quantitative 
myocardial perfusion MRI is still considered to be challenging and not completely 
understood. 
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A particularly challenging component in MBF quantification is the “extraction 
fraction.” In the case of a Gd-based tracer, the extraction fraction is the percentage of the 
tracer moving from the vascular space to the extracellular extravascular space (EES) [9]. 
The compartmental model-based approach to quantify DCE-CMR perfusion provides an 
estimate of forward transfer coefficient (𝐾𝑡𝑟𝑎𝑛𝑠), which is a product of MBF and the 
extraction fraction (𝐾𝑡𝑟𝑎𝑛𝑠=MBF x E). Thus, 𝐾𝑡𝑟𝑎𝑛𝑠 must be corrected for the extraction 
fraction, and failing to do so leads to an underestimation of the actual MBF [10]. Animal 
studies have calculated the extraction fraction in the canine myocardium [11, 12], and many 
studies on human myocardial perfusion use these published values. However, there have 
been studies to indicate that extraction fraction changes with flow [10]. Furthermore, 
studies using 99mTC-DTPA and 51CR-EDTA show that extraction fraction varies with 
flow in human and canine myocardium [13-15] and these inert diffusible tracers are similar 
to Gd-DTPA in terms of extraction fraction [16]. Thus, using published values for 
extraction fraction in perfusion studies is questionable. 
In their pioneering work, Larsson et al. tried to estimate extraction fraction as a 
parameter during pharmacokinetic modelling, but they were limited by the noise in the 
measured tissue curve signal and the complexity of the model they used [17]. A 
shortcoming with complex pharmacokinetic models is that identical tissue curves can be 
generated using a single arterial input function and multiple sets of perfusion model 
parameters. 
The goal of this study is to develop a novel technique that gives reliable estimates 
of extraction fraction during pharmacokinetic modelling. With the use of prior information 
from T1 mapping, it may be possible to improve quantitative perfusion estimates.  
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4.2 Theory 
Developments in cardiac MRI have made it possible to estimate extracellular 
volume (ECV) fraction using T1 mapping [1, 2]. ECV has been validated as a marker of 
myocardial fibrosis and infarction. Studies have shown good accuracy and repeatability for 
ECV estimation using T1 mapping [3-5]. Over these years, pharmacokinetic modelling of 
myocardial perfusion has also evolved. The possibility of estimating extracellular 
extravascular space (EES) or myocardial distribution volume using myocardial perfusion 
images has been studied with promising results [6, 7]. However, the prior studies have not 
looked at using ECV measured separately with T1 mapping to improve the perfusion 
studies. In this current study, we study the possibility of using ECV maps from T1 mapping 
to reduce the degrees of freedom when fitting a myocardial perfusion model. With the 
particular model chosen here, this also enables estimation of extraction fraction, along with 
perfusion.   
 
4.2.1 Pharmacokinetic modeling 
Gadolinium-based extracellular contrast agent permeates into the EES via the 




= 𝐾𝑡𝑟𝑎𝑛𝑠𝐶𝑏(𝑡 − ∆𝑇) − 𝑘𝑒𝑝𝐶𝑡(𝑡)                          (4.1) 
where, 𝐶𝑏 and 𝐶𝑡 represent the contrast concentration in blood (arterial) and tissue, 
respectively,  𝐾𝑡𝑟𝑎𝑛𝑠 and 𝑘𝑒𝑝 represent the forward transfer coefficient from blood to EES 
and the backward transfer coefficient from EES to blood, respectively. 
Solving the differential equation, we get, 
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𝐶𝑡(𝑡)=𝐶𝑏(𝑡 − ∆𝑇) ∗ 𝐾
𝑡𝑟𝑎𝑛𝑠𝑒−𝑘𝑒𝑝𝑡.                           (4.2) 
In the case of the myocardium, an additional term corresponding to the vascular 
component 𝑣𝑏 should be considered. This pharmacokinetic model with the additional 
vascular component term included is known as the extended Tofts-Kety model [8]. 
Moreover, the ratio of the forward and backward transfer constant, scaled by the blood 
hematocrit (Hct) value, represents the EES volume: 𝑣𝑒 = 𝐾
𝑡𝑟𝑎𝑛𝑠(1 − 𝐻𝑐𝑡) 𝑘𝑒𝑝⁄  [6]. Thus 
eq. (4.2) can be modified and written as: 






+ 𝑣𝑏𝐶𝑏(𝑡 − ∆𝑇).           (4.3) 
Since the gadolinium based contrast agent permeates into the EES, the above 
equation has to be corrected for the extraction [9]. Thus, we get, 






+ 𝑣𝑏(1 − 𝐸(𝑡))𝐶𝑏(𝑡 − ∆𝑇)    (4.4) 
where, E(t) is the extraction of the contrast agent from the intravascular space to the EES. 




                                         (4.5) 
where, 𝐶𝑜𝑢𝑡 represents the contrast concentration in blood on the venous side. 
Using Fick’s principle, we can write, 
𝑑𝐶𝑡(𝑡)
𝑑𝑡
= 𝐹(𝐶𝑏(𝑡) − 𝐶𝑜𝑢𝑡(𝑡))                                 (4.6) 
where, F represents the blood flow. 
Moreover, it is known that the forward transfer coefficient 𝐾𝑡𝑟𝑎𝑛𝑠 is related to the 
blood flow as: F=𝐾𝑡𝑟𝑎𝑛𝑠𝐸, where E represents the extraction fraction. Using eq. (4.6) along 
with the definition of extraction, we can write, 
𝐶𝑡 𝐶𝑣𝑎𝑠 
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].                                (4.7) 
Substituting this value of E(t) from eq. (4.7) into eq. (4.4). we get 
















].                       (4.8) 
Eq. (4.8) represents a 5-parameter model with  𝐾𝑡𝑟𝑎𝑛𝑠, 𝑣𝑒 , 𝛥𝑇, 𝑣𝑏  and 𝐸 as the 
parameters to be estimated. Larsson et al. reported that such a 5-parameter model does not 
have a unique convergence [9] and was not useful as a pharmacokinetic model for 
estimating myocardial perfusion in humans. However, due to the developments in cardiac 
MRI, it is now possible to estimate extracellular volume fraction ECV using T1 mapping. 
This additional information about ECV may improve perfusion estimates using the 5-
parameter model. 
 
4.2.2 Estimating ECV using T1 mapping 
The ECV in the myocardium can be estimated by taking the ratio of contrast agent 
concentration in the myocardium and the blood at dynamic steady-state [1].  











                            (4.9) 
where, Hct represents the measured hematocrit. This dynamic steady-state between the 
interstitium and the blood can be achieved by imaging approximately 15 min after the 
contrast agent injection. However, ECV includes the components corresponding to the 
extracellular extravascular space and also the extracellular intravascular space [10]. 
Hence, for accurate estimation of the EES, the component corresponding to 
 52 
extracellular intracellular volume needs to be subtracted [10] as follows: 
𝑣𝑒 = 𝐸𝐶𝑉. 𝜌 −  𝑣𝑝= 𝐸𝐶𝑉. 𝜌 − (1 − 𝐻𝑐𝑡)𝑣𝑏                    (4.10) 
where, 𝑣𝑒 represents the EES volume fraction, 𝑣𝑝 represents the volume fraction of blood 
plasma, 𝑣𝑏 represents the blood volume fraction and 𝜌 represents the specific gravity of 
myocardial tissue (1.05g/ml). 
With measured ECV, the 5-parameter model from eq. (4.8) reduces to a problem of 
estimating 4 parameters. This 5-parameter model with the use of ECV information will be 
referred to as a 4-parameter model in this article. This approach of fixing ECV in the model 
was evaluated using simulations and human studies.  
 
4.3 Materials and methods 
4.3.1 Simulation study 
Simulations were conducted to test the feasibility of using the 4-parameter model 
with known ECV and the 5-parameter model without known ECV. Physiologically realistic 
tissue residue curves were generated using the MMID4 perfusion model (National 
Simulation Resource, Department of Bioengineering, University of Washington, Seattle, 
WA). The MMID4 was run in the XSIM environment. MMID4 stands for multiple 
indicator, multiple path indicator dilution 4-region model. MMID4 is an axially distributed, 
physiologically realistic blood tissue exchange model that accounts for multiple parallel 
flow pathways. The model considers various parameters such as vascular flows, dispersion 
and the volume fractions for capillaries, arterioles, and arteries. MMID4 has been described 
in detail in [27, 28].  
To simulate realistic tissue residue curves, parameters for MMID4 were set using 
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previously validated experiments with healthy canine hearts [29]. These values have also 
been previously used for MMID4 simulations in studies for humans [30]. The large conduit 
vessel volume was fixed at 0.05ml/g (Vtube). The large vessel arterial (Vart) and arteriolar 
volumes (Vartl) were set to 0.02ml/g and 0.03ml/g, respectively. The capillary volume (Vp) 
was set to 0.05ml/g for resting flows and was changed to 0.09ml/g for stress flows. The 
large vessel volumes were not changed. Previous studies indicate that large vessel volumes 
do not change between rest and stress [31]. Relative dispersion (RD) was set to 0.48 for 
the upstream conduit vessel and the large vessels. For the simulation of tissue residue 
curves at rest and stress, flow values of 1ml/min/g and 2.8ml/min/g were selected 
respectively. Values for permeability-surface area (PS) were adjusted according to the 
Renkin-Crone equation to represent physiologically realistic values for extraction fraction 
as described in previous studies [10]. The value for interstitial volume EES (ve) was set 
and was assumed to be known. During model fitting, this know value of EES volume was 
allowed to vary by 5% of its actual value. This process of allowing the EES volume to vary 
slightly was found to give better model fits to the acquired data. 
Arterial input functions (AIF) corresponding to rest and stress were obtained from 
the same human study. These two input functions were then used to generate the tissue 
residue curves for flows during rest and stress. Figure 4.1 shows the AIF and tissue curves 
generated. Varying levels of Gaussian noise were added to the MMID4 tissue curves [17]. 
The noisy tissue residue curves were fit to the described four parameter model by 
minimizing the least squared error. Experiments were repeated without providing the 
model any information about EES (5 parameters were fit in this case). Figure 4.1 shows 
the example tissue curves corresponding to noise levels of 5%, 10%, and 15% noise during 
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rest and stress. Monte-Carlo simulations were done to evaluate the reliability of the 
perfusion parameter estimated by fitting the MMID4 tissue curves to the 4-parameter 
model as described above. One thousand experiments were performed at each noise level. 
Analysis of the results are described in the Statistical Analysis section below.  
 
4.3.2 In vivo study 
The study protocol involved acquisition of rest and stress perfusion data along with 
precontrast and postcontrast T1 mapping. Precontrast MOLLI T1 mapping was performed 
first, followed by a rest perfusion scan and phase contrast imaging to estimate coronary 
sinus flow. 
The rest perfusion scan was then followed by a stress perfusion scan and phase 
contrast imaging to estimate coronary sinus flow during stress. The rest and stress perfusion 
scans were separated by 20 ± 5min. Postcontrast MOLLI T1 mapping with scan parameters 
and slices similar to precontrast T1 mapping was performed approximately 12min after the 
contrast injection for stress perfusion. Figure 4.2 shows the summary of the acquisition 
protocol. The perfusion and T1 mapping portions of this dataset were also used in [20] 
 
4.3.2.1 Data acquisition 
Ten subjects (48 ± 12 years, eight males, two females) were imaged on a Siemens 
3T Verio scanner (Erlangen, Germany). Informed consent from the patients was obtained 
in accordance with the University of Utah Institutional Review Board. Hematocrit 
information was recorded for each subject. 
Precontrast and postcontrast T1 maps were acquired using a MOLLI work-in-
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progress package on the Siemens platform. The sequence employed the standard MOLLI 
technique that acquires images at 11 images at different inversion times. Each MOLLI slice 
was acquired within an end-expiration breath-hold by using an ECG-triggered acquisition 
with a balanced steady-state free precession (SSFP) readout (TR=2.8ms, TE=1.0ms, flip 
angle=35º, slice thickness=8mm, spatial resolution=1.8 x 1.8mm). The T1 mapping images 
were acquired in basal, mid and apical short-axis (SA) slices. Postcontrast MOLLI T1 
images were obtained approximately 10-15 min after the last injection of gadoteridol. 
The perfusion scans were performed using an ungated saturation recovery prepared 
TurboFLASH pulse sequence with golden angle radial acquisition. The acquisition 
parameters for the scans were 24 rays per image, TR = 2.2ms, TE = 1.2ms, flip angle = 10°, 
resolution = 1.8 × 1.8 × 8mm3 voxels. Four SA slices were acquired after a single saturation 
pulse with a saturation recovery time of ∼25ms before the first slice. Gadoteridol 
(ProHance; Bracco Diagnostic, Princeton, NJ) 0.05mmol/kg at a rate of 5mL/s was injected 
and ∼240 frames were acquired over a minute with shallow breathing and no ECG gating. 
This was followed 20 ± 5min later by an injection of regadenoson to induce stress. Contrast 
was injected ∼70s after regadenoson injection to ensure maximal stress and the scan 
protocol was repeated to acquire four slices at stress. Slices were acquired from base to 
apex. The slices were positioned such that slice 1 was as basal as possible without cutting 
through the valve plane.  
The radial k-space data were reconstructed offline using a multicoil spatio-
temporally constrained reconstruction with total variation constraint [32, 33]. Figure 4.3 
shows a single frame for reconstructed rest and stress perfusion images for 2 volunteers. In 
addition to the perfusion scans, mean MBF at rest and during stress was estimated using 
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phase contrast cine images of CS [34]. The CS was localized using the basal slices of the 
short-axis stack and the 4-chamber view in the atrio-ventricular groove. Velocity-encoded 
imaging was then acquired with ECG gating during breath holds. The scan parameters were 
slice thickness 6mm and velocity encoding 70cm/s. CS flow quantification was performed 
using commercial software (CVI42, Circle Cardiovascular Imaging Inc, Calgary, Canada). 
Phase-contrast magnitude images were used for contouring the coronary sinus throughout 
the cardiac cycle. Integration of flow rate from each cardiac phase over the entire cardiac 
cycle and mean heart rate during acquisition was used to calculate the CS flow both at rest 
and immediately after stress.  
 
4.3.2.2 Quantification of perfusion in the human datasets 
A subset of 6 subjects with reasonable CS flows was processed further for this 
study. The ungated datasets were self-gated into two discrete bins namely self-gated systole 
and self-gated diastole using the self-gating technique described in [35].  Only the self-
gated systolic datasets were used for further analysis during this study. This was done to 
minimize error due to the thinner walls in the diastolic datasets. The self-gated systolic 
datasets were registered automatically to account for respiratory motion and any residual 
cardiac motion after self-gating. The steps for processing self-gated datasets were 
described in detail in [35].  
The most basal slice (the slice with the lowest saturation recovery time, 25ms) was 
used to obtain the AIF. This acquisition of a short SRT AIF is similar to the dual sequence 
method. This process of obtaining a nonsaturated AIF was validated in [35]. The remaining 
three slices were used to quantify perfusion [20]. The slices were segmented by drawing 
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the epicardial and endocardial contours. The segmented myocardium was circumferentially 
divided into 6 segments. Tissue curves were obtained by recording the average signal 
intensity in each region over time. Tissue and AIF signal intensity tissue curves were 
converted to [Gd] assuming fast exchange of water [36].  
The tissue curves and AIF thus obtained were fit to the 4-parameter model as 
described in eq. (4.8). The precontrast and postcontrast MOLLI T1 mapping images were 
used to estimate ECV in three slices: basal, midventricular and apical. This information 
about ECV and hematocrit was supplied to the model during model fitting. The value of 
hematocrit was provided as a constant during the model fitting process. The value of ECV 
was allowed to vary by 5% of its actual value during model fitting. This process of allowing 
the ECV to vary slightly was found to give better model fits to the acquired data. During 
model fitting, the value of ECV was converted to EES volume using eq. (4.10).  
The same processing pipeline was followed for the rest and the stress datasets. The 
mean flows at rest and stress were compared to the CS flows. 
 
4.4 Statistical analysis 
4.4.1 Simulation study 
Mean and standard deviation (SD) were computed for the estimated perfusion 
parameters at various noise levels for the simulated tissue curves at rest and stress. Ninety-
five percent confidence intervals (CI) were calculated. Similar simulations were repeated 
with no prior information about ECV being supplied during model fitting.  
Sensitivity analysis was performed using the noise-free tissue curves. This was 
done to study the effect of variation of the perfusion parameters on their estimates. Three 
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sets of tissue curves were generated using MMID4. In the first set, 16 tissue curves were 
generated by varying MBF between 0.4-3.4ml/min/g in steps of 0.2ml/min/g and E and 
𝑣𝑏 were kept constant.  A fixed value of E=0.5 and 𝑣𝑏=0.05ml/g was used to generate all 
tissue curves with MBF<=1.6ml/min/g. The values of E and 𝑣𝑏 were updated to 0.35 and 
0.09ml/g for all tissue curves with MBF>1.6ml/min/g. This was done to generate 
physiologically realistic tissue curves representing rest and stress. For the second set, 9 
tissue curves were generated. The value of E was varied between 0.1-0.9 (in steps of 0.1). 
MBF=3ml/min/g and 𝑣𝑏=0.09ml/g was used to generate tissue curves with E<=0.5. The 
values of MBF and 𝑣𝑏 were changed to 1ml/min/g and 0.05ml/g for tissue curves with 
E>0.5. Fifteen tissue curves were generated in the third set by varying the value of 𝑣𝑏 
between 0.01-0.15ml/g (in steps of 0.01 ml/g). For reasons described earlier, 
MBF=1ml/min/g and E=0.5 were used for tissue curves generated with 𝑣𝑏<=0.08ml/g. 
MBF=3ml/min/g and E=0.35 were used for tissue curves with 𝑣𝑏>0.08ml/g. The generated 
tissue curves were fit to the 4-parameter model described above to estimate the perfusion 
parameters. Relative error, represented as a percentage, was determined as the ratio of 
difference between the estimated value and true value to the true value of the parameter.  
 
4.4.2 In vivo study  
Quantification of perfusion was done in a total of 108 myocardial segments (6 
subjects, 3 slices and 6 regions per slice) at rest and stress. MBF was estimated as the 
forward transfer coefficient (𝐾𝑡𝑟𝑎𝑛𝑠) divided by the extraction fraction (E). Mean and 
standard deviation were reported for MBF, E and 𝑣𝑏 during rest and stress.  Differences in 
these perfusion parameters during rest and stress were evaluated using the paired sample t-
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test. A value of p<0.05 was considered to be statistically significant.  
Global MBF was calculated as the average of MBF estimates over all slices and all 
regions for each subject. These global MBF estimates were compared to the CS flows using 
a paired-sample t-test. 
 
4.5 Results 
4.5.1 Simulation study 
Figure 4.4 shows the model fits to the noisy tissue curves (10% noise) generated 
using MMID4 with and without prior information about ECV. It can be seen that the model 
fits the measured noisy tissue curves correctly when additional information about ECV is 
provided. Figure 4.5 shows the boxplot of various perfusion parameters estimated with 
ECV provided during model fitting. Table 4.1 compares the statistics such as mean, SD 
and the 95% CI for the perfusion parameter estimates with and without prior information 
about ECV at rest and stress. With space constraints in mind, only the results for 5% and 
10% noise were presented in Table 4.1. It was seen that the 5% and 10% noise added tissue 
curves had a contrast to noise ratio (CNR, CNR=SIpeak/SDbaseline) comparable to the 
CNR calculated for the tissue curves from human datasets in this study. The boxplots and 
t-test show that the 4-parameter model converges to a unique solution and reliably 
estimates the perfusion parameters in presence of prior information on ECV. However, in 
absence of information on ECV, the 5-parameter model fails to converge to a unique 
solution and thus gives incorrect estimates for the perfusion parameters. The results of the 
simulation study show that the use of prior information makes it possible to reliably 
estimate extraction fraction as a perfusion parameter using the 4-parameter model.  
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Figure 4.6 shows the sensitivity analysis plots. The horizontal black line represents 
minimum error of 0%. A positive value for error indicates that the estimated value was 
more than the true value and vice versa.  
 
4.5.2 In vivo study 
Figure 4.7 shows an example of the 4-parameter model fit to measured tissue curves 
in a single myocardial region for 2 subjects during rest and stress. The mean MBF estimates 
for all 6 subjects during rest and stress were 0.9 ± 0.1ml/min/g and 2.3 ± 0.6ml/min/g 
respectively. The mean extraction fraction estimates were 0.49 ± 0.04 and 0.34 ± 0.05 
during rest and stress respectively. The estimates of extraction fraction at vasodilation were 
lower than those during rest. These estimates of extraction fraction are comparable to those 
found by other researchers in human and canine myocardium [10-12].   
Table 4.2 summarizes the values of extraction fraction reported by prior studies. 
Figure 4.8 shows a histogram representing the distribution of the different perfusion 
parameter estimates using the 4-parameter model. Figure 4.9 shows a comparison of the 
global MBF estimates to the CS flows. The paired sample t-test between the global MBF 
estimates and CS flows gave a p-value of p=0.65 and p=0.67 during rest and stress 
respectively, indicating that the global MBF estimates are not significantly different from 
the CS flows in this study. 
 
4.6 Discussion 
The main aim of this study is to look at the possibility of improved simultaneous 
estimation of forward transfer coefficient (𝐾𝑡𝑟𝑎𝑛𝑠) and extraction fraction (E) by using 
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ECV values from T1 measurements. The study makes use of a compartmental model 
approach and exploits the overlap in information provided by DCE-MRI and T1 mapping 
imaging techniques. The major findings of this study are: Extraction fraction and forward 
transfer coefficient can be simultaneously estimated when ECV is obtained separately, the 
model is robust to ECV variations within 10% of actual value, and consistent with more 
invasive findings, the extraction fraction estimates using the model were found to be lower 
at stress compared to rest [10, 13-15].  
The major advantage of using a compartmental model based approach for 
quantification of perfusion is the physiological interpretation for the model parameters [9]. 
However, compartment model-based approaches can be questioned when extraction 
fraction of the contrast agent is not part of the model. More complicated perfusion models 
such as the distributed parameter model, adiabatic tissue homogeneity (ATH) model, and 
MMID4 [38-40] make it possible to estimate the extraction efficiency along with the many 
other perfusion parameters. However, these models are complicated and sensitive to noise, 
and so the perfusion estimates using these complicated models may not be reliable. A 
recent work by Kunze et. al studied the estimation of microvascular perfusion 
characteristics such as ECV and PS along with blood flow using ATH and gamma capillary 
transit time model [24]. They agree that, despite being scan-time and contrast media dose 
efficient, such advanced models have higher implementation effort and post-processing 
complexity.  
Central volume principle-based models do not require the use of an extraction 
fraction to report absolute MBF [30, 41]. However, these approaches do not have a 
physiological interpretation of the parameters. Also the central volume principle based 
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approaches require expert knowledge during model fitting. For example, during Fermi 
model based analysis, care has to be taken to only include the first pass of the contrast 
agent. It is during this first pass that the signal changes are more sensitive to flow and not 
capillary permeability [41]. Hence an improper choice of the truncation point for the tissue 
curves may introduce errors. Similarly, the model-independent approach requires expert 
choice of regularization parameters. The myocardial perfusion estimates are dependent on 
the choice of these regularization parameters [42].  
Some two compartment model based studies make an assumption that the value for 
extraction fraction is fixed [34, 43]. Even if flow indices [44, 45] rather than MBF are 
considered, this would bias myocardial perfusion reserve (MPR) estimates.  That is, using 
nonextraction corrected compartment model-based flow indices may result in 
underestimation of MPR. However, some investigators have shown that nonextraction 
corrected compartment models give flows comparable to other validated models at rest 
[44]. Thus, further studies are needed to examine whether extraction fraction correction at 
rest and stress is necessary when using compartment models.  
The model fitting used in this study makes use of ECV estimates from MOLLI T1 
mapping for improving the perfusion estimates. The T1 mapping adds little time to the scan 
protocol. Moreover, according to the 2013 standardized protocols [46], precontrast and 
postcontrast T1 mapping should be included in the protocol for a cardiac MR exam.  
Estimation of ECV using MOLLI T1 mapping has been validated with high levels of 
precision and accuracy [20-22]. There have been studies indicating that use of MOLLI 
leads to an underestimation of T1, however, a systematic bias in T1 measurements leads to 
an error of 1% or less in ECV measurements [18].  
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One of the limitations of this study is the number of subjects in the study. Six 
subjects with reliable CS flow estimates and rest and stress perfusion studies were used as 
a proof of concept to estimate extraction fraction and perfusion index jointly. Further study 
with more subjects, including more with infarct and with other types of cardiac disease is 
recommended. Such a study would be helpful to better understand the changes in extraction 
fraction and flow with disease.  
The estimated value of 𝑣𝑏 for the human datasets was found to be lower compared 
to that reported by others at rest. The estimated values for 𝑣𝑏 showed an increase at stress 
as anticipated.  Moreover, the sensitivity analysis plots show that the 4-parameter model 
tends to underestimate 𝑣𝑏 compared to its true value during rest. Although this does not 
affect the estimates of MBF and extraction fraction (as seen from the simulation study), a 
study focusing on estimation of 𝑣𝑏 and its comparison with a gold standard could be useful. 
For the perfusion sequence in this study, multiple slices were acquired after a single 
saturation pulse. As a result, different slices have a different saturation recovery time and 
thus different signal intensities. To account for the difference in signal intensities between 
slices, the tissue curves were converted to [Gd] using Bloch equations and assuming fast 
exchange of water. This conversion assumes a saturation efficiency of 100% and that the 
prescribed flip angle is correct. A study by Broadbent et. al [47] found that a proton density 
based signal conversion technique as used here is robust to variations in saturation 
efficiency and flip angle. The assumption of fast water exchange may lead to errors in 
estimates of perfusion indices [48-50]. However, a systematic study by Larsson et. al 
looking at the effect of water exchange in DCE-MRI concluded that water exchange has 
negligible effect on estimates of perfusion parameters in the myocardium when a realistic 
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dose of Gd-DTPA is used and extraction fraction is greater than 0.3 [51]. The effects of 
water exchange were considered to be negligible during the current study. 
A prior study by Booker et. al. [52], looking at time-resolved CS flows after 
regadenoson administration, found that maximal CS flows were obtained ~75s (median, 
with a mean of ~102s) postadministration. Another study by DiBella et. al [53] found that 
contrast injection ~90s postregadenoson administration gave blood flow estimates 
comparable to those using adenosine. In light of these findings, we injected the contrast 
agent ~70s after regadenoson administration to image during maximal stress. However, the 
response to regadenoson may vary between people [54]. Similarly, the CS flow imaging 
following the stress perfusion scan may not be at maximal stress. Based on the results 
presented in [52], this difference between the actual recorded CS stress flows and CS 
maximal stress flows may be between 6-18% if imaged 1-3min after regadenoson 
administration. Further studies looking at time-resolved CS flows after regadenoson 
administration may help reduce the margin of error on measured flows. 
It is known that 𝑣𝑒 is significantly different between normal and infarcted 
myocardium. Two subjects in the study had a focused subendocardial infarct. The estimates 
of 𝑣𝑒 for these two subjects were obtained by excluding the infarct area. This study shows 
that it is possible to estimate extraction fraction and forward transfer coefficient 
simultaneously in large regions without infarct. The findings from this study may be 
extended into a separate study that looks at the effects of spatially varying ECV on 





A new approach combining the information from T1 mapping and DCE MRI was 
shown to reliably estimate perfusion parameters using a complex pharmacokinetic model. 
This technique makes it possible to quantify absolute MBF and extraction using a 
compartment model based approach. The technique exploits the overlap of information 
provided by two different cardiac MR imaging techniques. The approach opens the 
prospect of combining different imaging techniques to maximize the information obtained 
from a single patient study. 
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Figure 4.1: Figure shows the simulated tissue curves generated using MMID4 with 
various levels of Gaussian noise added in red.  First column represents rest and second 
column represents stress. The blue curves in the top row represent the AIFs used to 
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Figure 4.3: Figure shows a single slice from 2 different subjects in the study. Top row: 











Figure 4.4: Figure shows the noise added simulated tissue curves with the 4-parameter 
model fits with and without additional information about ECV. The model fits the data 
correctly in all cases. However, in absence of the prior information about ECV, the 


























Figure 4.5 Figure shows a boxplot of various perfusion parameters estimates with 
varying levels of Gaussian noise added (1%-15%). The first column represents rest and 















Figure 4.7: Figure shows a 4-parameter model fit to recorded tissue curves in a single 
myocardial region for 2 subjects during rest and stress. The inset text shows the estimate 






Figure 4.8 Histogram plots showing the distribution of various perfusion parameters 
estimated for all the 6 subjects in the study. Top row: Myocardial blood flow, middle 













Figure 4.9 Plot showing a comparison of global MBF estimates using pharmacokinetic 











mean  std. 
dev 
95% CI mean  std. 
dev 
95% CI 
5%   
 MBF (ml/min/g) 1 0.99  0.03 0.96-1.08 0.61  0.02 0.60-0.62 
 E 0.5 0.5  0.02 0.49-0.52 0.66  0.02 0.65-0.67 





10%   
 MBF (ml/min/g) 1 0.99  0.05 0.94-1.12 0.62  0.02 0.60-0.63 
 E 0.5 0.51  0.04 0.48-0.54 0.65  0.04 0.63-0.68 






5%       
 MBF (ml/min/g) 2.8 2.79  0.09 2.73-2.85 1.60  0.05 1.56-1.63 
 E 0.35 0.35  0.02 0.34-0.36 0.50  0.01 0.49-0.51 
 Vb (ml/g) 0.09 0.09  0.002 0.089-
0.091 
0.14  0.003 0.138-0.142 
10%       
 MBF (ml/min/g) 2.8 2.76  0.15 2.62-2.88 1.60  0.07 1.54-1.68 
 E 0.35 0.36  0.04 0.33-0.37 0.5  0.03 0.48-0.53 
 Vb (ml/g) 0.09 0.089  0.005 0.088-0.91 0.139  0.01 0.136-0.146 
Table 4.1 Table shows the statistics such as mean, SD and 95% CI for the perfusion parameters estimated 
















Prior studies Reported E 
Ishida et al.[11] Rest: 0.46, Stress: 0.32 
Diesbourg et al. [12] Rest: 0.5-0.6 
Tong et al.[13, 14] Rest: 0.5-0.6 
Haunso et al.[15] Rest: 0.4 
Svendsen et. al [16, 17] Rest: 0.51-0.55 








5.1 Ungated quantitative perfusion 
In the first project presented in this dissertation, (see Chapter 2) the possibility to 
quantify myocardial perfusion using a non-ECG gated acquisition is studied. Such an 
ungated acquisition has been previously studied for visual analysis. This is the first work 
using such an ungated acquisition for the quantification of myocardial perfusion. 
To test the accuracy, myocardial blood flow (MBF) estimates using the self-gated 
datasets are compared to those using the ECG-gated datasets. Comparisons are done in 7 
human datasets during rest. The regional blood flow estimates using the self-gated near 
systolic datasets (0.64 ± 0.26 ml/min/g) and the ECG-gated datasets (0.65 ± 0.28 ml/min/g) 
are seen to be similar. 
 
5.2 Interstudy repeatability of self-gated perfusion  
In the second project presented in this dissertation (see Chapter 3) the interstudy 
repeatability of myocardial blood flow estimates using the non-ECG gated acquisition 
technique is presented.  
To test the interstudy repeatability, 10 human subjects are scanned twice on 
separate days (9.5 ± 4.5 days). It is found that the territorial MPR using the self-gated near 
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systolic dataset is repeatable with a CoV of 18.6%. The CoV for the MBF estimates during 
rest and stress are 20.1% and 22.7% respectively using the near-systolic datasets. The self-
gated near-diastolic datasets do not have such a good repeatability. This may be attributed 
to the difficulties in processing the near-diastolic datasets. 
 
5.3 Estimation of extraction fraction 
In the third project presented in this dissertation (see Chapter 4), a technique to 
estimate the extraction fraction as a parameter during pharmacokinetic modelling is 
developed. The technique exploits the information overlap between two different cardiac 
MR imaging techniques namely, T1 weighted DCE imaging and T1 mapping.  
The technique is first tested using the MMID4 model simulations. This is followed 
by tests on six human datasets during rest and stress. The MBF estimates in the six datasets 
are compared to their corresponding global flow estimates using coronary sinus flow 
imaging. The paired sample t-test between the global MBF estimates and the CS flows give 
a p-value of p=0.65 and p=0.67 during rest and stress respectively, showing that the global 
MBF estimates are not significantly different from the CS flows. 
 
5.4 Summary of contributions 
The complexities associated with a quantitative cardiac perfusion exam have 
always been overshadowing its benefits. The development and use of a simpler acquisition, 
or a push-button technique, is the need of the hour. The cardiac push-button technique aims 
to simplify cardiac MR exams, wherein the MR technician does not have to worry about a 
good ECG signal or breath-hold instructions. The development of a non-ECG gated 
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technique for myocardial perfusion MRI is a step in the direction of such a 'push-button' 
acquisition protocol.  
Moreover, we strive to simplify quantitative cardiac perfusion further by 
developing a new technique that capitalizes on the information overlap between T1 
mapping and DCE MRI. The technique simplifies the process of quantification of perfusion 
by making it possible to use less complex pharmacokinetic models without sacrificing 
information. This study is a good example of the idea that information overlap between the 
different cardiac MR imaging techniques may be used together. The use of information 
overlap may be better exploited with the development and widespread use of hybrid 
imaging technologies such as the PET-MR scanners. We envision a day, when the clinician 
sitting in his/her office only gets a few plots/diagrams on their screen. These few results 
would give them all the information they need about the person's heart. The clinician will 
not have to worry about whether they are looking at perfusion images, T1 maps or LGE 
images. All they will see are the final quantitative results that have been generated for them 
by maximizing the information overlap between different cardiac imaging techniques. 
With these dreams, the studies presented in this dissertation aim to address few of 
the challenges faced by quantitative myocardial perfusion imaging. We strive to make it 
more simple and more accurate. These developments are in a direction to transition 
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